Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Litramine (IQP-G-002AS) is a patented natural fiber complex developed by InQpharm for weight management. [9, 10] It is derived from the prickly pear cactus (*Opuntia ficus-indica*) and enriched with soluble fibers from *Acacia sp*. [10] Litramine is classified as a medical device and acts via a physical mechanism within the gastrointestinal tract. [2] It binds to dietary fats, forming large fat-fiber complexes that are too large to be absorbed and are subsequently excreted. [10, 11] Additionally, the soluble fibers can swell in the stomach, which increases the feeling of satiety and helps reduce appetite. [8] Clinical studies have demonstrated its effectiveness and safety in promoting weight loss and, notably, in the long-term maintenance of body weight. [10] It is available over-the-counter and marketed under various brand names, including XLS Medical and I-REMOVE. [1, 3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on litramine.